title: Key Elements in Determining Voriconazole Protein Binding Characteristics: Comment on "Determination of Plasma Unbound Fraction of Voriconazole in Patients Treated With a Prophylactic or a Curative Treatment".
authors.affiliation: *Clinical Pharmacology and Pharmacotherapy, KU Leuven Department of Pharmaceutical and Pharmacological Sciences †Clinical Department of Laboratory Medicine, University Hospitals Leuven ‡Clinical Department of Haematology, Acute Leukaemia and Stem Cell Transplantation Unit, University Hospitals Leuven, Leuven, Belgium.
authors.forename: Kim
authors.initials: K
authors.lastname: Vanstraelen
authors.forename: Steven
authors.initials: S
authors.lastname: Pauwels
authors.forename: Matthijs
authors.initials: M
authors.lastname: Oyaert
authors.forename: Johan
authors.initials: J
authors.lastname: Maertens
authors.forename: Isabel
authors.initials: I
authors.lastname: Spriet
mesh_terms: D000935:Antifungal Agents / Q000008:administration & dosage* / Q000097:blood*; D016903:Drug Monitoring / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D065129:Pre-Exposure Prophylaxis; D065819:Voriconazole / Q000008:administration & dosage* / Q000097:blood*
chemical_list: D000935:Antifungal Agents; D065819:Voriconazole